Home › Fanconi Anemia › NCT07649031
MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients
RecruitingObservational study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients with a diagnosis of Fanconi Anemia who are willing to participate and willing to have MRIs * Willing to provide informed consent Exclusion Criteria: * Patient without diagnosis of FA * Patients with FA who are under the age of 18 * Unable to tolerate any MRI due to claustrophobia * Any contraindication for the MRI * Unable to provide informed consent or comply with the study protocol
About the study
This study being done to learn more about the use of medical Magnetic Resonance Imaging (mMRI) and dedicated dental MRI (ddMRI) as a non-invasive diagnosing tool when evaluating potential oral cancerous and precancerous lesions in Fanconi Anemia patients.
What is being tested
- MRIs (diagnostic test)
Sponsor: University of Minnesota · Participants: 80 · Started: Jun 23, 2026
Contact the study team
- Carla Campbell, BS · Phone: 612-625-6976
Official record on ClinicalTrials.gov — NCT07649031
Locations in the U.S.
| Minnesota | University of Minnesota, Minneapolis |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.